The company is a joint venture between Orthopaedic Research UK (85% shareholder), and Embryo Ventures Limited (15% shareholder).
At the year end, the company owed its majority shareholder, Orthopaedic Research UK, £27,480 (2023 £25,596). This amount is currently interest free and repayable on demand, but Orthopaedic Research UK has confirmed it will not withdraw its loan to the detriment of the company or its other creditors.The balance has arisen as Orthopaedic Research UK has covered the costs of the company's key services. If the company is able to secure external investment in the future, the company shall repay the loan to Orthopaedic Research UK plus interest.